Hyperpigmentation causée par la bléomycine: un rappel
Bleomycin is a chemotherapeutical cancer treatment generally for soft cell neoplasia Incidence of bleomycin-induced hyperpigmentation would reach 20% of all patients taking bleomycin The authors describe the case of a 23 year old woman who had ovarian dysgerminome. Treatment of bleomycin was given at a dosage of 30mg every week. 4 weeks after beginning the…